9 Clinical and endocopic improvement following hemopoietic stem cell transplantation in the ASTIC trial
C J Hawkey(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Séverine Vermeire(KU Leuven), Julian Lindsay(Royal North Shore Hospital), Jack Satsangi(Western General Hospital), Myriam Labopin(Sorbonne Université), Miquel Rovira, Silvio Danese(Università Cattolica del Sacro Cuore), Matthieu Allez(Inserm), Gerhard Rogler(University of Regensburg), Francesco Onida(Peter MacCallum Cancer Centre), Lauren Clark, A. R. Norman, Sandro Ardizzone(European CanCer Organisation), Simon Travis(John Radcliffe Hospital), Elizabeth Clark(University of Edinburgh), J.F. Colombel, NH Russell, Dominique Farge(Inserm), A Tyndall(University Hospital of Basel), E Ricart
Cited by 11
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
Extraintestinal Manifestations of Inflammatory Bowel Disease
|Inflammatory Bowel Diseases|2015|891